263 related articles for article (PubMed ID: 22555392)
1. Induced pluripotent stem cells in clinical hematology: potentials, progress, and remaining obstacles.
Panopoulos AD; Belmonte JC
Curr Opin Hematol; 2012 Jul; 19(4):256-60. PubMed ID: 22555392
[TBL] [Abstract][Full Text] [Related]
2. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation.
Paes BCMF; Moço PD; Pereira CG; Porto GS; de Sousa Russo EM; Reis LCJ; Covas DT; Picanço-Castro V
Cell Biol Toxicol; 2017 Jun; 33(3):233-250. PubMed ID: 28039590
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
[TBL] [Abstract][Full Text] [Related]
4. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
Hwang Y; Broxmeyer HE; Lee MR
Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
[TBL] [Abstract][Full Text] [Related]
5. Current status of producing autologous hematopoietic stem cells.
Li Z; Yang L
Curr Res Transl Med; 2023; 71(1):103377. PubMed ID: 36638755
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs contribute to induced pluripotent stem cell somatic donor memory.
Vitaloni M; Pulecio J; Bilic J; Kuebler B; Laricchia-Robbio L; Izpisua Belmonte JC
J Biol Chem; 2014 Jan; 289(4):2084-98. PubMed ID: 24311783
[TBL] [Abstract][Full Text] [Related]
7. Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture system.
Ruiz JP; Chen G; Haro Mora JJ; Keyvanfar K; Liu C; Zou J; Beers J; Bloomer H; Qanash H; Uchida N; Tisdale JF; Boehm M; Larochelle A
Stem Cell Res; 2019 Dec; 41():101600. PubMed ID: 31710911
[TBL] [Abstract][Full Text] [Related]
8. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
[TBL] [Abstract][Full Text] [Related]
9. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
[TBL] [Abstract][Full Text] [Related]
10. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.
Kambal A; Mitchell G; Cary W; Gruenloh W; Jung Y; Kalomoiris S; Nacey C; McGee J; Lindsey M; Fury B; Bauer G; Nolta JA; Anderson JS
Mol Ther; 2011 Mar; 19(3):584-93. PubMed ID: 21119622
[TBL] [Abstract][Full Text] [Related]
11. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cells in hematology: current and future applications.
Focosi D; Amabile G; Di Ruscio A; Quaranta P; Tenen DG; Pistello M
Blood Cancer J; 2014 May; 4(5):e211. PubMed ID: 24813079
[TBL] [Abstract][Full Text] [Related]
13. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.
Suzuki N; Yamazaki S; Yamaguchi T; Okabe M; Masaki H; Takaki S; Otsu M; Nakauchi H
Mol Ther; 2013 Jul; 21(7):1424-31. PubMed ID: 23670574
[TBL] [Abstract][Full Text] [Related]
14. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
[TBL] [Abstract][Full Text] [Related]
15. Making a Hematopoietic Stem Cell.
Daniel MG; Pereira CF; Lemischka IR; Moore KA
Trends Cell Biol; 2016 Mar; 26(3):202-214. PubMed ID: 26526106
[TBL] [Abstract][Full Text] [Related]
16. Concise review: programming human pluripotent stem cells into blood.
Easterbrook J; Fidanza A; Forrester LM
Br J Haematol; 2016 Jun; 173(5):671-9. PubMed ID: 26996518
[TBL] [Abstract][Full Text] [Related]
17. Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells.
Lee J; Dykstra B; Sackstein R; Rossi DJ
Curr Opin Hematol; 2015 Jul; 22(4):317-23. PubMed ID: 26049752
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo expansion of hematopoietic cells and their clinical use.
Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli RM; Olivieri A; Siena S; Zanon P; Tura S
Haematologica; 1998 Sep; 83(9):824-48. PubMed ID: 9825579
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator.
Ferreira AF; Calin GA; Picanço-Castro V; Kashima S; Covas DT; de Castro FA
J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29467236
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells.
Hexum MK; Tian X; Kaufman DS
Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
